| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8225249 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 5 Pages |
Abstract
PMRT offers excellent control for patients with 1-3 LN+, with no locoregional failures to date. Patients with 1-3 LN+ who have grade III disease and/or ECE should be strongly considered for PMRT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Rahul D. MD, Sana BS, Monica E. MD, Chandana A. MS, Halle MD, G. Thomas MD, Jill MD, Joseph P. MD, Roger MD,